Goitre

Overview

Thyroid enlargement from compensatory hyperplasia+hypertrophy in response to hormone deficiency. Generally EUTHYROID end-result (unlike Graves’). 2 forms: DIFFUSE(simple/colloid) vs NODULAR(multinodular/adenomatous).

Pathogenesis

Shared mechanism — nodular = END-STAGE of long-standing simple goitre (SINGLE fact tying whole topic together). Deficient hormone(usually iodine)→↑TSH→follicular hyperplasia+new follicles. Cyclical hyperplastic→involution=simple goitre. REPEATED cycles→continued growth+involuted-area fibrosis=nodular goitre.

Diffuse goitre (simple/colloid)

Diffuse enlargement, NO hyperthyroidism. Mostly euthyroid(±preceding hypothyroid phase). ↑TSH invariably. More FEMALES. Often puberty/adolescence onset→regress OR progress to nodular.

Etiology — 2 forms: ENDEMIC — >10% population prevalence. Mountainous low-iodine regions(Himalayas/Alps/Andes). DECLINING with iodised salt (clean public-health case study). Also: GOITROGENS(antithyroid drugs, cabbage/cauliflower/turnips/cassava), genetic factors.

SPORADIC(non-endemic) — less common, mostly unknown. Factors: suboptimal iodine at ↑demand(puberty/pregnancy), genetic, dietary goitrogens, hereditary synthesis/transport defects(dyshormonogenesis), inborn iodine metabolism errors.

Morphology: Gross=moderate(≤100-150g), symmetric, diffuse, gelatinous translucent brown. Micro (2 stages):

1. HYPERPLASTIC(early) — tall columnar epithelium, papillary infoldings, new small follicles
2. INVOLUTION(follows) — large colloid-distended follicles, FLATTENED epithelium

Nodular goitre (multinodular/adenomatous)

END-STAGE of long-standing simple goitre. MOST EXTREME tumour-like enlargement, characteristic nodularity. →cosmetic disfigurement, dysphagia/choking(oesophagus/trachea compression). Mostly euthyroid; ~10%→thyrotoxicosis(TOXIC NODULAR GOITRE/PLUMMER’S DISEASE) — DISTINGUISHED from Graves’ by ABSENCE of ophthalmopathy+dermatopathy (KEY discriminator — eye/skin findings specific to Graves’ autoimmune mechanism, not thyrotoxicosis generally). ±“hot nodules” on CT/RAIU. Same female preponderance as diffuse but OLDER (late complication).

Etiology: shares diffuse goitre factors; nodularity mechanism unclear — likely hyperplasia+new follicles+irregular colloid→tension/stress→follicle/vessel rupture→haemorrhage+cystic change+scarring+±calcification.

Morphology: Gross=asymmetric, extreme(100-500+g). 5 CARDINAL features: nodularity+poor encapsulation, fibrous scarring, haemorrhages, focal calcification, cystic degeneration. Usually multinodular, POORLY circumscribed — UNLIKE complete encapsulation of thyroid adenoma (MOST IMPORTANT morphologic distinguisher when dominant nodule raises neoplasm suspicion — cross-ref Thyroid Neoplasms). Micro: partial/incomplete encapsulation; variable follicle size/epithelium height, ±macropapillary; haemorrhage+haemosiderin macrophages+cholesterol crystals; fibrous scarring+calcification; micro-macrocystic change.

Comparison

Clinical relevance

Nodular=end-stage of simple goitre = organising fact — every feature(nodularity/scarring/calcification/cysts) = accumulated damage from repeated cycles over years. Poor encapsulation(nodular goitre) vs COMPLETE encapsulation(true adenoma) = MOST important distinguisher for dominant-nodule workup — cross-ref Thyroid Neoplasms. Toxic nodular goitre lacking ophthalmopathy/dermatopathy = key discriminator from Graves’ in thyrotoxic+nodular presentation. Iodised salt→↓endemic goitre = clean dietary-intervention public-health case study.

Overview

Goitre is thyroid enlargement caused by compensatory hyperplasia and hypertrophy of follicular epithelium in response to thyroid hormone deficiency. The end result is generally a euthyroid state (unlike the thyrotoxicosis of diffuse toxic goitre/Graves’ disease), though hypo- or hyperthyroid phases may occur at certain stages. Two morphologic forms: diffuse goitre (simple nontoxic/colloid goitre) and nodular goitre (multinodular/adenomatous goitre).

Pathogenesis

Both forms share pathogenetic mechanisms, since nodular goitre is generally regarded as the end-stage of long-standing simple goitre. The fundamental defect is deficient thyroid hormone production (most commonly dietary iodine lack), causing excessive TSH stimulation → follicular epithelial hyperplasia and new follicle formation. A cyclical hyperplastic stage followed by an involution stage completes the simple goitre picture. Repeated, prolonged hyperplasia cycles cause continued thyroid tissue growth, while involuted areas undergo fibrosis — together producing nodular goitre.

Diffuse Goitre (Simple Non-toxic/Colloid Goitre)

Diffuse thyroid enlargement without hyperthyroidism. Most cases are euthyroid, though they may have passed through a preceding hypothyroid phase from inadequate iodine. TSH levels are invariably elevated. More common in females; often appears at puberty/adolescence, after which it may regress or progress to nodular goitre.

Etiology — two epidemiologic forms:

Endemic goitre — prevalence >10% of a geographic population; occurs in mountainous regions far from the sea with low dietary/water iodine (Himalayas, Alps, Andes); declining with iodised salt prophylaxis. Besides iodine deficiency, some cases result from goitrogens (substances interfering with thyroid hormone synthesis — antithyroid drugs, and foods like cabbage, cauliflower, turnips, cassava roots) and genetic factors.

Sporadic (non-endemic) goitre — less common, mostly unknown etiology. Contributing factors: suboptimal iodine intake during increased demand (puberty, pregnancy), genetic factors, dietary goitrogens, hereditary thyroid hormone synthesis/transport defects (dyshormonogenesis), inborn iodine metabolism errors.

Morphology: Gross — moderate (up to 100–150 g), symmetric, diffuse enlargement; gelatinous, translucent brown cut surface. Micro — two stages:

1. Hyperplastic stage (early) — tall columnar follicular epithelium with papillary infoldings, new small follicle formation.
2. Involution stage (follows after variable time) — large colloid-distended follicles lined by flattened epithelium.

Nodular Goitre (Multinodular/Adenomatous Goitre)

The end-stage of long-standing simple goitre — the most extreme degree of tumour-like thyroid enlargement, with characteristic nodularity. Enlargement can cause cosmetic disfigurement and, from oesophageal/tracheal compression, dysphagia and choking. Most cases are euthyroid, but ~10% develop thyrotoxicosis (toxic nodular goitre/Plummer’s disease) — distinguished from Graves’ disease by the absence of ophthalmopathy and dermatopathy. “Hot nodules” may be identified by CT or RAIU. Shares diffuse goitre’s female preponderance but affects older individuals, being a late complication.

Etiology: shares diffuse goitre’s etiologic factors, but the mechanism producing nodularity specifically is unclear — likely epithelial hyperplasia, new follicle generation, and irregular colloid accumulation together create tension/stress, causing follicle/vessel rupture, followed by haemorrhage, cystic change, scarring, and sometimes calcification.

Morphology: Gross — asymmetric, extreme enlargement (100–500+ g). Five cardinal macroscopic features: nodularity with poor encapsulation, fibrous scarring, haemorrhages, focal calcification, cystic degeneration. Usually multinodular (occasionally 1–2 nodules), poorly circumscribed — unlike the complete encapsulation of a thyroid adenoma. Micro (mirrors gross heterogeneity): partial/incomplete nodule encapsulation; follicles varying small to large, flat to high epithelium, ± macropapillary formation; haemorrhage areas with haemosiderin-laden macrophages and cholesterol crystals; fibrous scarring with calcification foci; micro-macrocystic change.

Diffuse vs Nodular Goitre — Comparison

Clinical Relevance

• Nodular goitre being conceptually “the end-stage of simple goitre” is the single fact that ties this entire topic together — every gross/micro feature of nodular goitre (nodularity, scarring, calcification, cysts) is just the accumulated damage of repeated hyperplasia-involution cycles over years.
• The poorly-circumscribed, incompletely-encapsulated nature of nodular goitre nodules versus the complete encapsulation of thyroid adenoma is the single most important morphologic distinguisher when a dominant nodule in a multinodular gland raises suspicion for a true neoplasm — worth cross-referencing against the Thyroid Neoplasms topic.
• Toxic nodular goitre (Plummer’s disease) lacking ophthalmopathy/dermatopathy is the key clinical discriminator from Graves’ disease when a patient presents with thyrotoxicosis and a nodular gland — the eye and skin findings are specific to Graves’ autoimmune mechanism, not to thyrotoxicosis in general.
• The iodised-salt-driven decline in endemic goitre prevalence is a clean public-health case study of how a single dietary intervention can reshape disease epidemiology at a population level.

• Pathogenesis pathway: iodine deficiency → ↑TSH → hyperplasia-involution cycling → simple goitre → repeated cycles → nodular goitre, as a progression timeline
• Diffuse vs nodular goitre gross appearance side by side, with the encapsulation difference from a true thyroid adenoma marked

Short Answers (1)